FPRT BIO, INC.

Biotech · Private

XPro1595, a selective soluble TNF antagonist therapeutic for treatment-resistant depression

fprtbio.com →
Grants
$350K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel Dominant Negative TNF Inhibitors for Treatment of Depression$350,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1278EDITPEP INC—$8.2M
1279DNATWO, INC.——
1280ASYMMETREX, LLC——
1281FPRT BIO, INC.——
1282ADVANCED VIROLOGY INC.——
1283IMMUNE MODULATORY THERAPIES, LLC——
1284XLOCK BIOSCIENCES, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.